Pond Technologies Holdings Inc. ( TSX.V:POND ) ( OTCQB:PNDHF ) , an ESG company addressing global sustainability challenges of wellness and climate change, just announced that it has met another milestone under the previously announced contract with a major Fortune 500 Oil and Gas company. Pond Technologies ( TSX.V:POND ) ( OTCQB:PNDHF ) has received an additional $350,000 payment for completing this milestone, bringing the total amount earned from the contract to $580,000.
To reach this critical milestone, the company isolated recombinant proteins from Pond -grown algae that had to function as good as or better than conventionally generated proteins in a lateral flow diagnostic test. Lateral flow studies employing Pond-grown recombinant proteins successfully tested for COVID-19 antibodies in August, and they were more reactive than conventional proteins.
Pond Technologies ( TSX.V:POND ) ( OTCQB:PNDHF ) has been delivering recombinant proteins to the project consortium for weekly testing since the beginning of 2022. This material has demonstrated that algae-grown recombinant proteins perform equally well in diagnostic tests as traditionally manufactured proteins. These experiments’ findings were recently published in the scholarly journal Nature Scientific Reports.
“The successful completion of this...
Click here to read the full article on PressReach.com .Subscribe to the PressReach RSS feeds:
- Featured News RSS feed
- Investing News RSS feed
- Daily Press Releases RSS feed
- Trading Tips RSS feed
- Investing Videos RSS feed
Follow PressReach on Twitter
Follow PressReach on TikTok
Follow PressReach on Instagram
Subscribe to us on Youtube